Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ash Access Technology
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ash Access Technology

Ash Access Technology

US-based Ash Access Technology innovates devices to treat and prevent vascular access-related diseases.

HQ
Lafayette, IN, US
Founded
1983
Overview
Compare
Fundraising
Employees
Website

Founded in Lafayette, United States, Ash Access Technology is a medical device company dedicated to developing technologies and devices aimed at treating and preventing vascular access-related diseases. Their core mission is to enhance patient safety and efficacy in vascular access procedures. The company focuses on creating innovative solutions that address the clinical consequences of these conditions, thereby improving patient outcomes in the healthcare market.

Notable figures affiliated with Ash Access Technology include Dr. Stephen R. Ash, a nephrologist and serial inventor who serves as Chief Scientist, and Robert B. Truitt, the CEO known for his commercialization and fundraising expertise. The company has made significant strides in the medical field, benefiting numerous patients worldwide through their groundbreaking innovations. Their impact is evident in the improved safety and effectiveness of vascular access treatments, marking them as a key player in the medical device industry.

Ash Access Technology - Similar Companies

Access Vascular logo

Access Vascular

Bluegrass Vascular Technologies logo

Bluegrass Vascular Technologies

Phraxis logo

Phraxis

phraxis.com

Vital Access logo

Vital Access

vital-access.com

Arstasis logo

Arstasis

arstasis.com

Attwill Vascular Technologies logo

Attwill Vascular Technologies

I-V Access Technology logo

I-V Access Technology

ivatinc.com

Traverse Vascular logo

Traverse Vascular

Vasc-Alert logo

Vasc-Alert

vasc-alert.com

Hemova Medical logo

Hemova Medical

Radux Devices logo

Radux Devices

raduxdevices.com

Versago Vascular Access logo

Versago Vascular Access

Solinas Medical logo

Solinas Medical

solinasmedical.com

Baton Rouge Vascular Access logo

Baton Rouge Vascular Access

Medical Device Innovations logo

Medical Device Innovations

Ash Access Technology - Quick Facts

Who are Ash Access Technology's competitors?

Companies similar to Ash Access Technology include Access Vascular, Bluegrass Vascular Technologies, Phraxis and Vital Access.

When was Ash Access Technology founded?

Ash Access Technology was founded in 1983.

Where is Ash Access Technology's headquarters located?

Ash Access Technology's headquarters is located in Lafayette, IN, US.

When was Ash Access Technology's last funding round?

Ash Access Technology's most recent funding round was for $453k (USD) in June 2010.

How much has Ash Access Technology raised to-date?

As of Jun 4, 2010, Ash Access Technology has raised a total of $453k (USD).

How many employees does Ash Access Technology have?

Ash Access Technology has 7 employees as of Feb 5, 2024.

Ash Access Technology - Classification

Industry
  • Hardware
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 7 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8733Noncommercial Research Organizations
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified